论文部分内容阅读
在印度西部的Karad的E型肝炎流行期间,从1993年1月至3月作者对妊娠妇女使用的一种印度产血清免疫球蛋白功效进行了评价。在随访的1个月期间,55名使用ISG的妇女中有10名产生抗-HEV IgM,而不使用ISG的53名妇女中有18名产生抗-HEV IgM。尽管ISG使用组新感染HEV的总数有明显减少,但由于发展为临床疾病的病人数很少,E型肝炎的临床发病率在两组之间并没有表现出显著的差异。所观察到的ISG
During the epidemiology of hepatitis E in Karad, western India, the efficacy of an Indian serum-producing immunoglobulin for pregnant women from January to March 1993 was evaluated. During the 1-month follow-up, 10 of 55 ISG-producing women developed anti-HEV IgM, whereas 18 of 53 women not using ISG developed anti-HEV IgM. Although there was a significant reduction in the total number of newly infected HEVs in the ISG-treated group, the clinical incidence of hepatitis E did not show a significant difference between the two groups as the number of patients developing clinical disease was small. The observed ISG